"Organic order intake increased by more than 20% in the third quarter, with a strong performance in all business areas and regions," says Mattias Perjos, President & CEO at
"We achieved a milestone during the quarter when we completed our remediation measures under the Consent Decree with the FDA at our production site in Hechingen,
July - September 2021 in brief- The order intake increased organically by 21.8% and net sales declined organically by 20.1%.
-
Adjusted gross profit amounted to
SEK 3,334 M (4,378) and the gross margin was 52.9% (54.9). -
Adjusted EBITA amounted to
SEK 1,160 M (2,028) and the EBITA margin was 18.4% (25.4). -
Adjusted earnings per share amounted to
SEK 2.96 (5.37). -
Cash flow after net investments amounted to
SEK 1,380 M (1,567).
A conference call will be held on
SE: + 46 8 566 426 92
US: + 1 646 722 4903
During the conference call a presentation will be held. To access the presentation through webcast, please use this link: https://tv.streamfabriken.com/getinge-q3-2021
Alternatively, use the following link to download the presentation:
https://www.getinge.com/int/about-us/investors/reports-presentations/
Agenda
09:45 Dial in to the conference
10:00 Presentation
10:30 Q&A
11:00 End of conference
Recording available for 3 years
A recorded version can be accessed for 3 years via https://tv.streamfabriken.com/getinge-q3-2021
Media contact:
Tel: +46 (0)10 335 0043
Email: lars.mattsson@getinge.com
This information is such that
About
With a firm belief that every person and community should have access to the best possible care,
https://news.cision.com/getinge/r/getinge-q3-report-2021---strong-order-intake-and-our-remediation-measures-completed-in-germany-,c3435800
https://mb.cision.com/Main/942/3435800/1483314.pdf
https://mb.cision.com/Public/942/3435800/9a58b27b349807e5.pdf
https://news.cision.com/getinge/i/getinge-maquet-volista-visionir,c2969289
https://news.cision.com/getinge/i/mattias-perjos,c2969290
(c) 2021 Cision. All rights reserved., source